Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire
- PMID: 2983820
- PMCID: PMC1418595
- DOI: 10.1136/bmj.290.6471.808
Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire
Abstract
A human retrovirus--human T cell lymphotropic virus-III (HTLV-III)--has recently emerged as the probable cause of acquired immunodeficiency syndrome (AIDS). In May 1984, 250 outpatients at a hospital in a remote area of eastern Zaire were surveyed for AIDS type illnesses and the prevalence of antibodies against HTLV-III determined by an enzyme linked immunosorbent assay using disrupted whole HTLV-III virus as the antigen. No clinical cases of AIDS were diagnosed among these patients. Overall, 31 (12.4%) had clearly positive ratios (greater than or equal to 5.0) and a further 30 (12.0%) had borderline ratios (3.0- less than 5.0). Western blots of serum samples from subjects with antibodies yielded bands consistent with HTLV-III as found in American patients with AIDS and members of groups at risk of AIDS. The prevalence of antibody was highest in childhood (p = 0.02); among adults prevalence rose slightly with age. HTLV-III antibodies were more common among the uneducated (p = 0.006), agricultural workers (p = 0.03), and rural residents (p = 0.006), but the Western blot bands were generally weak in this group. By contrast, one urban resident had strong bands. The relatively high prevalence of antibodies among the rural poor in this area of Zaire suggests that HTLV-III or a closely related, cross reactive virus may be endemic in the region. A different natural history of infection, perhaps in childhood, may also explain the findings.
Similar articles
-
Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians.Int J Cancer. 1985 Sep 15;36(3):373-8. Int J Cancer. 1985. PMID: 2993173
-
IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.Br Med J (Clin Res Ed). 1985 Jul 20;291(6489):165-6. doi: 10.1136/bmj.291.6489.165. Br Med J (Clin Res Ed). 1985. PMID: 2990634 Free PMC article.
-
Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.JAMA. 1986 Aug 8;256(6):721-4. JAMA. 1986. PMID: 3014178
-
A pathogenic retrovirus (HTLV-III) linked to AIDS.N Engl J Med. 1984 Nov 15;311(20):1292-7. doi: 10.1056/NEJM198411153112006. N Engl J Med. 1984. PMID: 6208484 Review.
-
The AIDS problem in Africa.Lancet. 1986 Jan 11;1(8472):79-83. doi: 10.1016/s0140-6736(86)90728-2. Lancet. 1986. PMID: 2867324 Review.
Cited by
-
Comparison of enzyme immunoassays and an immunofluorescence test for detection of antibody to human immunodeficiency virus in African sera.Eur J Clin Microbiol. 1987 Apr;6(2):132-5. doi: 10.1007/BF02018193. Eur J Clin Microbiol. 1987. PMID: 3297680
-
Infectious diseases in Africa.Infection. 1987 May-Jun;15(3):153-9. doi: 10.1007/BF01646036. Infection. 1987. PMID: 2886436 Review.
-
Epidemiological evidence that HTLV-III is the AIDS agent.Eur J Epidemiol. 1985 Sep;1(3):155-9. doi: 10.1007/BF00234088. Eur J Epidemiol. 1985. PMID: 2945735
-
Seroepidemiology of human immunodeficiency virus in Africa.Br Med J (Clin Res Ed). 1986 Sep 27;293(6550):782-5. doi: 10.1136/bmj.293.6550.782. Br Med J (Clin Res Ed). 1986. PMID: 3094656 Free PMC article.
-
Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.J Clin Microbiol. 2016 Dec 28;55(1):165-176. doi: 10.1128/JCM.01979-16. Print 2017 Jan. J Clin Microbiol. 2016. PMID: 27795350 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical